Depatuxizumab
Product Specifications
CAS Number
1471999-69-5
Target
EGFR
Related Pathways
Angiogenesis|||Tyrosine Kinase/Adaptors|||JAK/STAT signaling
Purity
0.993
Bioactivity
Depatuxizumab is a humanised monoclonal antibody targeting EGFR with blood-brain barrier (BBB) permeability, capable of inhibiting the growth of xenograft tumours expressing mutant EGFR vIII and wild-type EGFR. It can be conjugated with the ADC molecule Depatuxizumab mafodotin for the study of glioblastoma (GBM) and head and neck squamous cell carcinoma (SCCHN) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
126537-APC 100 µL
F13A1 (Coagulation Factor XIII A Chain, Coagulation Factor XIIIa, Protein-glutamine gamma-glutamyltransferase A Chain, Transglutaminase A Chain, F13A) (APC)
Ask
View Details